Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses is incomplete, which has severely hampered the development of effective …
Achieving clinical remission with hypomethylating agents enhances survival for patients with high-risk myelodysplastic syndrome, new data shows.
Dr. Cytryn provides insights on the FDA approval of zolbetuximab and how it will impact clinical practice.
Dr. Neal Shore discusses the ABLE-32 study on the use of nadofaragene firadenovec for intermediate-risk, BCG-unresponsive non-muscle invasive bladder cancer.
The expert panel moderated by Prithviraj Bose, MD, tells which research presented at the Meeting they found most exciting.
Datopotamab deruxtecan showed “encouraging and durable antitumor activity” in patients with heavily pretreated advanced or metastatic non-small cell lung cancer.
This novel JAK2 inhibitor features reduced off-target suppression of JAK1, JAK3, TYK2, and other kinases.
A “significant number” of young survivors of testicular cancer report that their social, financial, and sexual health are “enduring the negative sequelae” of testicular cancer.
Experts warn that snow shoveling can pose serious health risks, particularly for older adults and those with preexisting conditions.
Yale Medicine cardiac specialists discuss what causes high blood pressure (hypertension) and how to best treat it.
